Literature DB >> 3500161

beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.

D M Livermore1, P Y Chau, A I Wong, Y K Leung.   

Abstract

beta-Lactamase production was examined in nine strains of Pseudomonas pseudomallei isolated from human, animal and environmental sources in Thailand and Hong Kong. All produced the same weakly inducible, membrane associated chromosomal cephalosporinase, which had a molecular weight of 29,500 and an isoelectric point of 7.4-7.7. The enzyme resembled the cefuroximases of Ps. cepacia and Proteus vulgaris, but differed from the Class I cephalosporinases typical of Ps. aeruginosa and most enterobacteria, in being strongly active against carbenicillin, cefotaxime and cefuroxime and in being inactivated readily by clavulanic acid. Synergy experiments with clavulanic acid investigated the enzyme's contribution to antibiotic resistance, and these results broadly correlated with those of in-vitro hydrolysis assays. Thus, ampicillin, carbenicillin, cefoperazone, cefotaxime, cefuroxime and cephalothin, which were hydrolysed in vitro, were potentiated four to 64-fold by 2 mg/l clavulanic acid; but cefoxitin, ceftazidime, cloxacillin and imipenem, which appeared stable in vitro, were potentiated four-fold or less.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500161     DOI: 10.1093/jac/20.3.313

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.

Authors:  Terence K M Cheung; P L Ho; Patrick C Y Woo; K Y Yuen; P Y Chau
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.

Authors:  T Sookpranee; M Sookpranee; M A Mellencamp; L C Preheim
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Natnaree Saiprom; Narisara Chantratita; Wirongrong Chierakul; Gavin C K W Koh; Wipada Chaowagul; Nicholas P J Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

4.  Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.

Authors:  Jessica R Webb; Erin P Price; Bart J Currie; Derek S Sarovich
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Novel beta-lactamase from Capnocytophaga sp.

Authors:  J E Foweraker; P M Hawkey; J Heritage; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei.

Authors:  Linnell B Randall; Karen Dobos; Krisztina M Papp-Wallace; Robert A Bonomo; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

9.  Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Authors:  Anne-Sophie Morin; Laurent Poirel; Francine Mory; Roger Labia; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 10.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.